Arbutus Biopharma Corporation ABUS

Set alert

Price alert · ABUS

All alert types
4.21 USD -0.07 -1.64%

At close · Oct 30

4.21 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
4.21 × 2
Ask
4.22 × 2
4.14 Day range 4.30
3.67 52-week range 5.22
YTD
-12.47%
1 year
-13.02%
Open
4.28
Prev close
4.28
Mkt cap
645.29M
Vol
2.53M
Avg vol
4.88M
EPS
0.79
P/E
5.33
Div yield
0.00%
More statistics
Low
4.14
High
4.30
Forward P/E
-30.67
Beta
0.62
Short ratio
5.03
Inst. own
72.71%
Dividend
0.00
Ex-div date
Earnings
Nov 16, 2026
50-d avg
4.79
200-d avg
4.52
1y target
5.46

MAX chart

Chart tools
Interval

Events in this range
  • Nov 4, 2010Split: 0.2 for 1
  • Aug 6, 2025Earnings: 0.01; estimate -0.02; surprise 150%
Signals (63)
NameDateAgo
SMA: BearishOct 1, 20261 month ago
MACD: Sell SignalOct 1, 20261 month ago
SMA: BullishAug 1, 20263 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BearishApr 1, 20267 months ago
MACD: Buy SignalSep 1, 20251 year ago
SMA: BullishAug 1, 20251 year ago
MACD: Sell SignalJun 1, 20251 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BullishFeb 1, 20242 years ago
MACD: Buy SignalJan 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
MACD: Sell SignalJul 1, 20233 years ago
SMA: BearishMay 1, 20233 years ago
MACD: Buy SignalFeb 1, 20233 years ago
SMA: BullishJan 1, 20233 years ago
SMA: BearishApr 1, 20224 years ago
MACD: Sell SignalMar 1, 20224 years ago
SMA: BullishFeb 1, 20224 years ago
SMA: BearishJan 1, 20224 years ago
SMA: BearishJan 1, 20224 years ago
SMA: BullishDec 1, 20214 years ago
SMA: BearishNov 1, 20215 years ago
SMA: BullishSep 1, 20215 years ago
SMA: BearishMar 1, 20215 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BullishJul 1, 20206 years ago
SMA: BearishJun 1, 20206 years ago
SMA: BullishMay 1, 20206 years ago
MACD: Buy SignalMay 1, 20206 years ago
SMA: BearishMar 1, 20206 years ago
MACD: Sell SignalMar 1, 20206 years ago
MACD: Buy SignalFeb 1, 20206 years ago
SMA: BullishDec 1, 20196 years ago
MACD: Sell SignalDec 1, 20187 years ago
SMA: BearishOct 1, 20188 years ago
SMA: BearishOct 1, 20188 years ago
RSI: OverboughtJul 1, 20188 years ago
SMA: BullishSep 1, 20179 years ago
SMA: BullishMar 1, 20179 years ago
MACD: Buy SignalMar 1, 20179 years ago
SMA: BearishJun 1, 201511 years ago
MACD: Sell SignalApr 1, 201511 years ago
SMA: BearishMar 1, 201511 years ago
SMA: BullishJan 1, 201511 years ago
SMA: BearishOct 1, 201412 years ago
SMA: BullishAug 1, 201412 years ago
RSI: OverboughtAug 1, 201412 years ago
SMA: BearishJul 1, 201412 years ago
RSI: OverboughtJan 1, 201412 years ago
RSI: OverboughtSep 1, 201313 years ago
SMA: BullishOct 1, 201214 years ago
MACD: Buy SignalMay 1, 201214 years ago
SMA: BullishFeb 1, 201214 years ago
SMA: BearishMar 1, 201115 years ago
MACD: Sell SignalMar 1, 201115 years ago
SMA: BearishNov 1, 201016 years ago
SMA: BullishMay 1, 201016 years ago
SMA: BullishMar 1, 201016 years ago
SMA: BearishDec 1, 200916 years ago
SMA: BullishApr 1, 200917 years ago
SMA: BearishJun 1, 200818 years ago

Discussion (236)

Sign in to join the discussion

Chris Ford ABUS 6 months ago #1

We want the cancer cure and the fast track gets us closer.

Chris Ford ABUS 8 months ago #3

At least we can confirm we got more cash on the way.

Chris Ford ABUS 8 months ago #4

Bizzaro blocking on basic shit

Chris Ford ABUS 8 months ago #5

…as a reference point. They used it.

Chris Ford ABUS 8 months ago #6

Its the conclusion of how you got to and endpoint without a patent. If they used a patent as a reference point. They used it in my opinion.

Chris Ford ABUS 8 months ago #7

Last time we checked we wanted the shit to work. Why didn’t you use the patents?

Chris Ford ABUS 8 months ago #8

Was there a compelling reason to not use the patents available to them? What efforts did they make to justify not using proven technology and what scientific justification did they come to not use the patents that were available?

Chris Ford ABUS 8 months ago #9

Why couldn’t they just collaborate and support the scientific process? They took ABUS work and maliciously used it without regard to the science they actually paid for.

Chris Ford ABUS 8 months ago #10

The same ones they licensed. No null hypothesis. It will be easy to show they copied and pasted with no scientific process to alter proven patents they used.